期刊文献+

胃肠道间质瘤形态学及免疫组化研究 被引量:3

Morphologic and immunohistochemical study of gastrointestinal stromal tumor
下载PDF
导出
摘要 目的研究胃肠道间质瘤(GIST)的病理形态及免疫组化特点。方法应用光镜观察50例GIST的形态特征,用免疫组化S-P法检测CD117、CD34、Vimentin、Desmin、SMA及S-100蛋白在GIST中的表达情况。结果GIST的瘤细胞较经典的平滑肌瘤更丰富,胞质嗜酸性较弱。瘤细胞梭形或上皮样,或梭形与上皮样细胞混合存在,胞质内常见空泡形成;瘤细胞排列成交织束状、弥漫片状、栅栏状或轮辐状,较为特征的是细胞团巢形成。常见间质或血管壁玻璃样变。原发于肠系膜者恶性潜力较高。CD117和CD34的阳性率分别为98%和92%。结论胃肠道间质瘤有较为独特的组织学形态,CD117和CD34联合使用可协助鉴别诊断。 Objective It is to study the pathomorphological and immunohistochemical features of gastrointestinal stromal tumor (GIST). Methods The morphologic characteristies of 55 GIST patients were observed with light microscopy, The expressions of CDl17, CD34, Vimentin, Desmin, SMA and S 100 protein in GIST were detected with S-P immunohisto- chemical method. Results GIST had higher degree of cellularity and lesser degree of eosinophilia than classic leiomyomas, The neoplastic cell of GIST was spindle, epithelioid or both in different proportions. Focal to prominent cytoplasmic vacuolization was often seen. The histological spectrum included interlacing fascicles, diffuse sheets, storiform and palisading pattern, The fomation of cell clusters was rather special, Stromal and vascular hyalinization was common, GIST primary in the mesentery had higher potentiality of malignancy. The masculine rates of CDll7 and CD34 were 98 % and 92 % respec- tively, Conclusion GIST has characteristic histological features, The combination detection of CDll7 and CD34 is helpful to differential diagnosis,
出处 《现代中西医结合杂志》 CAS 2007年第29期4264-4266,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 胃肠道间质瘤 形态学 病理学 免疫组织化学 gastrointestinal stromal tumor morphology pathology immunohistochemistry
  • 相关文献

参考文献9

  • 1Deslva CM,Re DR.Gastrointestinal stromal tumors(GIST):C-Kit mutation,CD117 expression,differential diagnosis and targeted cancer therapy with imatinib[J].Pathol Oncol Res,2003,9(1):13-19
  • 2Juan Rosa.Ackerman's Surgical Pathology[M].8th ed.U.S.A:Mosby,1996:646-658
  • 3彭贵勇,房殿春,李向红.消化道黏膜下肿瘤的超声内镜诊断及治疗[J].世界华人消化杂志,2004,12(1):133-136. 被引量:27
  • 4Graadtvanroggen JF,Vanvelthuysen ML,Hogendoorn PC.The histopathological differential diagnosis of gastrointestinal stromal tumors[J].J Clin Pathol,2001,54(2):96-102
  • 5Erlandson RA,Klimstra DS,Woodnuff JM.Subclassification of gastrointestinal stromal tumors based on evolution by electron mircroscopy and immuneohistochemistry[H].Ultrastruct Pathol,1996,20(2):373-393
  • 6Kindblom LG,Remotti HE,Aldenberg F,et al.Gastrointestinal P.acemaker cell tumors(GIPACT):gastrointestinal stromal tumors show phenoltypic characteristics of the intestinal cell of Cajal[J].Am J Pathol,1998,152(5):1259-1269
  • 7Franquemont DW.Differentiation and risk assessment of gastrointestinal stromal tumors[J].Am J Clin Pathol,1995,103(1):41-47
  • 8于冬梅,孙慧勤,阎晓初.胃肠道间质瘤研究进展[J].消化外科,2003,2(6):453-456. 被引量:4
  • 9沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27

二级参考文献24

  • 1JOENSUU H;Fletcher C;Dimitrijevic S.Management of malignant gastrointestinal stromal tumours[J],2002.
  • 2DeMatteo RP;Heinrich MC;El-Rifai WM.Clinical management of gastrointestinal stromal tumors:before and after STI-571[J],2002.
  • 3Sakurai S;Fukasawa T;Chong JM.Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal[J],1999.
  • 4Sarlomo-Rikala M;Kovatich AJ;Barusevicius A.CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34,1998.
  • 5Sircar K;Hewlett BR;Huizinga JD.Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors[J],1999.
  • 6Fletcher CD;Berman JJ;Corless C.Diagnosis of gastrointestinal stromal tumors:a consensus approach[J],2002.
  • 7Tuveson DA;Willis NA;Jacks T.STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications[J],2001(36).
  • 8Van Oosterom AT;Judson I;Verweij J.Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study[J],2001.
  • 9Benjamin RS;Rankin C;Fletcher C.Phase Ⅲ dose-randomized study of imatini Mesylate (STI571) for GIST: intergroup S0033 early results (abstract 3271),2003.
  • 10VERWEIJ J;Casali PG;Zalcberg J.Early efficacy comparison of two doses of imatini for the treatment of advanced gastro-intestinal stromal tumoars(GIST): interm results of a randomized phase Ⅲ trial from the EORTC-STBSG,ISG and AGITG (abstract 3272),2003.

共引文献53

同被引文献33

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部